Related Experiment Video
Updated: Jun 24, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 24, 2014
Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura
Nicholas S Abend1, Daniel J Licht, Charles H Spencer
1Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. abend@email.chop.edu
Abstract:
A male adolescent developed a sinovenous thrombosis 4 weeks following a Henoch-Schonlein purpura episode. A hypercoagulation evaluation revealed a positive lupus anticoagulant. This suggests an association between Henoch-Schonlein purpura and antiphospholipid antibody syndrome and is the first report of sinovenous thrombosis after Henoch-Schonlein purpura that was likely due to elevated antiphospholipids. Children who develop Henoch-Schonlein purpura with neurologic features including headache should be evaluated for sinovenous thrombosis and a hypercoagulable state.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Nephrotic Syndrome I : Introduction

